ID   RTN4R_MOUSE             Reviewed;         473 AA.
AC   Q99PI8; Q80WQ1;
DT   25-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   07-APR-2021, entry version 167.
DE   RecName: Full=Reticulon-4 receptor;
DE   AltName: Full=Nogo receptor;
DE            Short=NgR {ECO:0000303|PubMed:15504325};
DE   AltName: Full=Nogo-66 receptor {ECO:0000303|PubMed:15504325};
DE   AltName: Full=Nogo66 receptor-1 {ECO:0000303|PubMed:22406547};
DE            Short=NgR1 {ECO:0000303|PubMed:22406547};
DE   Flags: Precursor;
GN   Name=Rtn4r; Synonyms=Ngr1, Nogor;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Swiss Webster;
RX   PubMed=11201742; DOI=10.1038/35053072;
RA   Fournier A.E., GrandPre T., Strittmatter S.M.;
RT   "Identification of a receptor mediating Nogo-66 inhibition of axonal
RT   regeneration.";
RL   Nature 409:341-346(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   REVIEW.
RX   PubMed=11891768; DOI=10.1002/jnr.10134;
RA   Ng C.E.L., Tang B.L.;
RT   "Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron
RT   regeneration.";
RL   J. Neurosci. Res. 67:559-565(2002).
RN   [4]
RP   INTERACTION WITH MAG, AND FUNCTION.
RX   PubMed=12089450; DOI=10.1126/science.1073031;
RA   Liu B.P., Fournier A., GrandPre T., Strittmatter S.M.;
RT   "Myelin-associated glycoprotein as a functional ligand for the Nogo-66
RT   receptor.";
RL   Science 297:1190-1193(2002).
RN   [5]
RP   DISRUPTION PHENOTYPE, FUNCTION, INTERACTION WITH RTN4, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15504325; DOI=10.1016/j.neuron.2004.10.015;
RA   Kim J.E., Liu B.P., Park J.H., Strittmatter S.M.;
RT   "Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration
RT   and limits functional recovery from spinal cord injury.";
RL   Neuron 44:439-451(2004).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=15647357; DOI=10.1073/pnas.0409026102;
RA   Zheng B., Atwal J., Ho C., Case L., He X.L., Garcia K.C., Steward O.,
RA   Tessier-Lavigne M.;
RT   "Genetic deletion of the Nogo receptor does not reduce neurite inhibition
RT   in vitro or promote corticospinal tract regeneration in vivo.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1205-1210(2005).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18411262; DOI=10.1074/jbc.m802067200;
RA   Williams G., Wood A., Williams E.J., Gao Y., Mercado M.L., Katz A.,
RA   Joseph-McCarthy D., Bates B., Ling H.P., Aulabaugh A., Zaccardi J., Xie Y.,
RA   Pangalos M.N., Walsh F.S., Doherty P.;
RT   "Ganglioside inhibition of neurite outgrowth requires Nogo receptor
RT   function: identification of interaction sites and development of novel
RT   antagonists.";
RL   J. Biol. Chem. 283:16641-16652(2008).
RN   [8]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19052207; DOI=10.1523/jneurosci.3828-08.2008;
RA   Budel S., Padukkavidana T., Liu B.P., Feng Z., Hu F., Johnson S.,
RA   Lauren J., Park J.H., McGee A.W., Liao J., Stillman A., Kim J.E.,
RA   Yang B.Z., Sodi S., Gelernter J., Zhao H., Hisama F., Arnsten A.F.,
RA   Strittmatter S.M.;
RT   "Genetic variants of Nogo-66 receptor with possible association to
RT   schizophrenia block myelin inhibition of axon growth.";
RL   J. Neurosci. 28:13161-13172(2008).
RN   [9]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19367338; DOI=10.1371/journal.pone.0005218;
RA   Woerter V., Schweigreiter R., Kinzel B., Mueller M., Barske C., Boeck G.,
RA   Frentzel S., Bandtlow C.E.;
RT   "Inhibitory activity of myelin-associated glycoprotein on sensory neurons
RT   is largely independent of NgR1 and NgR2 and resides within Ig-Like domains
RT   4 and 5.";
RL   PLoS ONE 4:E5218-E5218(2009).
RN   [10]
RP   FUNCTION.
RX   PubMed=20093372; DOI=10.1093/cercor/bhp307;
RA   Mathis C., Schroeter A., Thallmair M., Schwab M.E.;
RT   "Nogo-a regulates neural precursor migration in the embryonic mouse
RT   cortex.";
RL   Cereb. Cortex 20:2380-2390(2010).
RN   [11]
RP   FUNCTION, INTERACTION WITH MAG; OLFM1; LINGO1 AND NGFR, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=22923615; DOI=10.1074/jbc.m112.389916;
RA   Nakaya N., Sultana A., Lee H.S., Tomarev S.I.;
RT   "Olfactomedin 1 interacts with the Nogo A receptor complex to regulate axon
RT   growth.";
RL   J. Biol. Chem. 287:37171-37184(2012).
RN   [12]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=22406547; DOI=10.1038/nn.3070;
RA   Dickendesher T.L., Baldwin K.T., Mironova Y.A., Koriyama Y., Raiker S.J.,
RA   Askew K.L., Wood A., Geoffroy C.G., Zheng B., Liepmann C.D., Katagiri Y.,
RA   Benowitz L.I., Geller H.M., Giger R.J.;
RT   "NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans.";
RL   Nat. Neurosci. 15:703-712(2012).
RN   [13]
RP   DISRUPTION PHENOTYPE, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=22325200; DOI=10.1016/j.neuron.2011.11.029;
RA   Wills Z.P., Mandel-Brehm C., Mardinly A.R., McCord A.E., Giger R.J.,
RA   Greenberg M.E.;
RT   "The Nogo receptor family restricts synapse number in the developing
RT   hippocampus.";
RL   Neuron 73:466-481(2012).
RN   [14]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=26335717; DOI=10.1038/cddis.2015.228;
RA   Palandri A., Salvador V.R., Wojnacki J., Vivinetto A.L., Schnaar R.L.,
RA   Lopez P.H.;
RT   "Myelin-associated glycoprotein modulates apoptosis of motoneurons during
RT   early postnatal development via NgR/p75(NTR) receptor-mediated activation
RT   of RhoA signaling pathways.";
RL   Cell Death Dis. 6:E1876-E1876(2015).
RN   [15]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=27339102; DOI=10.1002/cne.24064;
RA   Yoo S.W., Motari M.G., Schnaar R.L.;
RT   "Agenesis of the corpus callosum in Nogo receptor deficient mice.";
RL   J. Comp. Neurol. 525:291-301(2017).
RN   [16] {ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L, ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N, ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P, ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 26-337, SUBUNIT, GLYCOSYLATION AT
RP   ASN-82; ASN-179 AND ASN-372, AND DISULFIDE BONDS.
RX   PubMed=29095159; DOI=10.1107/s2059798317013791;
RA   Pronker M.F., Tas R.P., Vlieg H.C., Janssen B.J.C.;
RT   "Nogo Receptor crystal structures with a native disulfide pattern suggest a
RT   novel mode of self-interaction.";
RL   Acta Crystallogr. D 73:860-876(2017).
CC   -!- FUNCTION: Receptor for RTN4, OMG and MAG (PubMed:11201742,
CC       PubMed:12089450, PubMed:15504325, PubMed:18411262, PubMed:22923615).
CC       Functions as receptor for the sialylated gangliosides GT1b and GM1
CC       (PubMed:18411262). Besides, functions as receptor for chondroitin
CC       sulfate proteoglycans (PubMed:22406547). Can also bind heparin
CC       (PubMed:22406547). Intracellular signaling cascades are triggered via
CC       the coreceptor NGFR (By similarity). Signaling mediates activation of
CC       Rho and downstream reorganization of the actin cytoskeleton
CC       (PubMed:22325200). Mediates axonal growth inhibition (By similarity).
CC       Mediates axonal growth inhibition and plays a role in regulating axon
CC       regeneration and neuronal plasticity in the adult central nervous
CC       system (PubMed:11201742, PubMed:12089450, PubMed:15504325,
CC       PubMed:22923615). Plays a role in postnatal brain development
CC       (PubMed:27339102). Required for normal axon migration across the brain
CC       midline and normal formation of the corpus callosum (PubMed:27339102).
CC       Protects motoneurons against apoptosis; protection against apoptosis is
CC       probably mediated via interaction with MAG (PubMed:26335717). Acts in
CC       conjunction with RTN4 and LINGO1 in regulating neuronal precursor cell
CC       motility during cortical development (PubMed:20093372). Like other
CC       family members, plays a role in restricting the number dendritic spines
CC       and the number of synapses that are formed during brain development
CC       (PubMed:22325200). {ECO:0000250|UniProtKB:Q9BZR6,
CC       ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:12089450,
CC       ECO:0000269|PubMed:15504325, ECO:0000269|PubMed:20093372,
CC       ECO:0000269|PubMed:22325200, ECO:0000269|PubMed:22406547,
CC       ECO:0000269|PubMed:22923615, ECO:0000269|PubMed:26335717,
CC       ECO:0000269|PubMed:27339102}.
CC   -!- SUBUNIT: Homodimer (PubMed:29095159). Interacts with MAG
CC       (PubMed:12089450). Interacts with RTN4 (PubMed:15504325). Interacts
CC       with NGFR(PubMed:22923615). Interacts with LINGO1(PubMed:22923615).
CC       Interacts with KIAA0319L (By similarity). Interacts with OLFM1; this
CC       inhibits interaction with LINGO1 and NGFR (PubMed:22923615). Interacts
CC       with OMG (By similarity). {ECO:0000250|UniProtKB:Q99M75,
CC       ECO:0000250|UniProtKB:Q9BZR6, ECO:0000269|PubMed:12089450,
CC       ECO:0000269|PubMed:15504325, ECO:0000269|PubMed:22923615,
CC       ECO:0000269|PubMed:29095159}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11201742,
CC       ECO:0000269|PubMed:22325200}; Lipid-anchor, GPI-anchor
CC       {ECO:0000269|PubMed:11201742}. Membrane raft
CC       {ECO:0000250|UniProtKB:Q9BZR6}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:22325200}. Cell projection, axon
CC       {ECO:0000269|PubMed:22325200}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q99M75}. Note=Detected along dendrites and
CC       axons, close to synapses, but clearly excluded from synapses.
CC       {ECO:0000269|PubMed:22325200}.
CC   -!- TISSUE SPECIFICITY: Detected in embryonic hippocampus neurons
CC       (PubMed:22325200). Detected in brain (at protein level)
CC       (PubMed:15504325, PubMed:22406547). Detected in neurons in the
CC       neocortex, in hippocampus, dorsal thalamus, cerebellum granule cell
CC       layer and the mitral cell layer in the olfactory bulb
CC       (PubMed:15647357). Detected in brain, dorsal root ganglion and heart.
CC       {ECO:0000269|PubMed:11201742, ECO:0000269|PubMed:15504325,
CC       ECO:0000269|PubMed:15647357, ECO:0000269|PubMed:22325200,
CC       ECO:0000269|PubMed:22406547, ECO:0000269|PubMed:22923615}.
CC   -!- PTM: N-glycosylated (PubMed:29095159). O-glycosylated. Contains
CC       terminal sialic acid groups on its glycan chains (By similarity).
CC       {ECO:0000250|UniProtKB:Q99M75, ECO:0000269|PubMed:29095159}.
CC   -!- DISRUPTION PHENOTYPE: Mice are born at the expected Mendelian rate, are
CC       viable and fertile (PubMed:15504325, PubMed:15647357). They display
CC       subtle changes in exploratory behavior, manifest deficits in spatial
CC       working memory performance, and show impaired ability to stay on a
CC       rotarod (PubMed:15504325 and PubMed:19052207). Compared to wild-type
CC       littermates, cultured hippocampus neurons from mutant mice display an
CC       increased number of excitatory synapses (PubMed:22325200). Effects on
CC       neurite outgrowth are controversial and may depend on the mouse strain,
CC       cell type, and the experimental conditions (PubMed:15504325,
CC       PubMed:15647357, PubMed:18411262, PubMed:19367338). Cultured neurons
CC       display impaired axon growth cone collapse in response to myelin, MAG
CC       and RTN4 (PubMed:15504325). Mutant cerebellar and dorsal root ganglion
CC       neurons show no decrease of the inhibition of neurite outgrowth by
CC       myelin or RTN4 (PubMed:15647357). Mutant cerebellar neurons display
CC       decreased inhibition of neurite outgrowth mediated by MAG and by cross-
CC       linking ganglioside GT1b (in vitro) (PubMed:18411262). Likewise, mutant
CC       sensory neurons show no decrease of the inhibition of neurite outgrowth
CC       by MAG (PubMed:19367338). Mutant mice have improved functional recovery
CC       and increased regeneration of rubrospinal and raphespinal fibers after
CC       spinal cord transection. Still, there is no regeneration of
CC       corticospinal fibers (PubMed:15504325, PubMed:15647357). Mice lacking
CC       both Rtn4r and Rtn4rl2 display no visible phenotype (PubMed:19367338).
CC       Sensory neurons from mice lacking both Rtn4r and Rtn4rl2 show
CC       moderately decreased inhibition of neurite outgrowth by MAG
CC       (PubMed:19367338). Mice with a triple gene disruption that lack Rtn4r,
CC       Rtn4rl1 and Rtn4rl2 have no visible phenotype, are healthy and viable
CC       (PubMed:22406547). Mice with a triple gene disruption that lack Rtn4r,
CC       Rtn4rl1 and Rtn4rl2 have normal brain size and grossly normal brain
CC       anatomy, but display disruption of medial brain structures, including
CC       an absence of the fasciola cinereum, corpus callosum agenesis and
CC       formation of bilateral Probst bundles indicative of the failure of
CC       callosally projecting neurons to extend across the midline
CC       (PubMed:27339102). Mice with a triple gene disruption of Rtn4r, Rtn4rl1
CC       and Rtn4rl2 display impaired ability to stay on a rotarod and increased
CC       spontaneous locomotion (PubMed:27339102). These mice display an
CC       increased number of excitatory synapses in the apical dendritic regions
CC       of hippocampus neurons, an increase in the complexity of dendrite
CC       structure and increased total dendrite length (PubMed:22325200). One
CC       month after birth, mice with a triple gene disruption that lack Rtn4r,
CC       Rtn4rl1 and Rtn4rl2 show a significant reduction in the survival of
CC       motoneurons (PubMed:26335717). Compared to wild-type or single mutants,
CC       cerebellar granule cells from mice lacking Rtn4r, Rtn4rl1 and Rtn4rl2
CC       show decreased myelin-mediated inhibition of neurite outgrowth, an
CC       inhibition that is strongly decreased on myelin deficient in Mag, Rtn4
CC       and Omg (PubMed:22406547). Mice lacking both Rtn4r and Rtn4rl1 show
CC       increased axon regeneration after injury; the same effect is observed
CC       when Rtn4r, Rtn4rl1 and Rtn4rl2 are disrupted (PubMed:22406547).
CC       Combined disruption of Rtn4r, Rtn4rl1 and Ptprs further increases axon
CC       regeneration after injury (PubMed:22406547). Single gene disruption of
CC       Rtn4r, Rtn4rl1 and Rtn4rl2 and combined disruption of Rtn4r and Rtn4rl2
CC       have no effect on axon regeneration (PubMed:22406547).
CC       {ECO:0000269|PubMed:15504325, ECO:0000269|PubMed:15647357,
CC       ECO:0000269|PubMed:18411262, ECO:0000269|PubMed:19052207,
CC       ECO:0000269|PubMed:19367338, ECO:0000269|PubMed:22325200,
CC       ECO:0000269|PubMed:22406547, ECO:0000269|PubMed:26335717,
CC       ECO:0000269|PubMed:27339102}.
CC   -!- SIMILARITY: Belongs to the Nogo receptor family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Nerve regrowth: nipped by a
CC       no-go - Issue 69 of April 2006;
CC       URL="https://web.expasy.org/spotlight/back_issues/069";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF283462; AAG53611.1; -; mRNA.
DR   EMBL; BC052317; AAH52317.2; -; mRNA.
DR   EMBL; BC058381; AAH58381.1; -; mRNA.
DR   CCDS; CCDS37279.1; -.
DR   RefSeq; NP_075358.1; NM_022982.2.
DR   PDB; 5O0K; X-ray; 2.30 A; A/B=27-337.
DR   PDB; 5O0L; X-ray; 2.51 A; A/B=27-337.
DR   PDB; 5O0M; X-ray; 1.90 A; A/B=26-337.
DR   PDB; 5O0N; X-ray; 2.50 A; A=27-337.
DR   PDB; 5O0O; X-ray; 2.20 A; A/B/C/D/E/F/G/H=27-337.
DR   PDB; 5O0P; X-ray; 2.00 A; A/B=26-348.
DR   PDB; 5O0Q; X-ray; 2.50 A; A/B/C/D=26-348.
DR   PDB; 5O0R; X-ray; 2.50 A; A/B=26-348.
DR   PDBsum; 5O0K; -.
DR   PDBsum; 5O0L; -.
DR   PDBsum; 5O0M; -.
DR   PDBsum; 5O0N; -.
DR   PDBsum; 5O0O; -.
DR   PDBsum; 5O0P; -.
DR   PDBsum; 5O0Q; -.
DR   PDBsum; 5O0R; -.
DR   SMR; Q99PI8; -.
DR   BioGRID; 211123; 2.
DR   CORUM; Q99PI8; -.
DR   IntAct; Q99PI8; 1.
DR   MINT; Q99PI8; -.
DR   STRING; 10090.ENSMUSP00000062924; -.
DR   GlyConnect; 2681; 1 N-Linked glycan (2 sites).
DR   GlyGen; Q99PI8; 4 sites.
DR   iPTMnet; Q99PI8; -.
DR   PaxDb; Q99PI8; -.
DR   PeptideAtlas; Q99PI8; -.
DR   PRIDE; Q99PI8; -.
DR   ProteomicsDB; 256638; -.
DR   ABCD; Q99PI8; 1 sequenced antibody.
DR   Antibodypedia; 23162; 358 antibodies.
DR   Ensembl; ENSMUST00000059589; ENSMUSP00000062924; ENSMUSG00000043811.
DR   Ensembl; ENSMUST00000213627; ENSMUSP00000149817; ENSMUSG00000111113.
DR   GeneID; 65079; -.
DR   KEGG; mmu:65079; -.
DR   UCSC; uc007ymv.1; mouse.
DR   CTD; 65078; -.
DR   MGI; MGI:2136886; Rtn4r.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000160711; -.
DR   HOGENOM; CLU_000288_18_6_1; -.
DR   InParanoid; Q99PI8; -.
DR   OMA; MDKSFIY; -.
DR   OrthoDB; 826997at2759; -.
DR   PhylomeDB; Q99PI8; -.
DR   TreeFam; TF330080; -.
DR   BioGRID-ORCS; 65079; 1 hit in 53 CRISPR screens.
DR   PRO; PR:Q99PI8; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   RNAct; Q99PI8; protein.
DR   Bgee; ENSMUSG00000043811; Expressed in primary visual cortex and 146 other tissues.
DR   Genevisible; Q99PI8; MM.
DR   GO; GO:0031362; C:anchored component of external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0044295; C:axonal growth cone; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0043198; C:dendritic shaft; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:MGI.
DR   GO; GO:0030426; C:growth cone; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098793; C:presynapse; ISO:MGI.
DR   GO; GO:0035374; F:chondroitin sulfate binding; IDA:UniProtKB.
DR   GO; GO:1905573; F:ganglioside GM1 binding; ISS:UniProtKB.
DR   GO; GO:1905576; F:ganglioside GT1b binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; IDA:UniProtKB.
DR   GO; GO:0038131; F:neuregulin receptor activity; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0048495; F:Roundabout binding; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; ISO:MGI.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0007409; P:axonogenesis; IDA:MGI.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0022038; P:corpus callosum development; IMP:UniProtKB.
DR   GO; GO:0050919; P:negative chemotaxis; IBA:GO_Central.
DR   GO; GO:0030517; P:negative regulation of axon extension; IDA:UniProtKB.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; IMP:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0023041; P:neuronal signal transduction; IDA:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; ISS:UniProtKB.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF13855; LRR_8; 2.
DR   SMART; SM00369; LRR_TYP; 8.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Disulfide bond; Glycoprotein;
KW   GPI-anchor; Heparin-binding; Leucine-rich repeat; Lipoprotein; Membrane;
KW   Receptor; Reference proteome; Repeat; Signal.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..447
FT                   /note="Reticulon-4 receptor"
FT                   /id="PRO_0000022257"
FT   PROPEP          448..473
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000022258"
FT   DOMAIN          27..57
FT                   /note="LRRNT"
FT   REPEAT          58..79
FT                   /note="LRR 1"
FT   REPEAT          82..103
FT                   /note="LRR 2"
FT   REPEAT          106..128
FT                   /note="LRR 3"
FT   REPEAT          131..152
FT                   /note="LRR 4"
FT   REPEAT          155..176
FT                   /note="LRR 5"
FT   REPEAT          179..200
FT                   /note="LRR 6"
FT   REPEAT          203..224
FT                   /note="LRR 7"
FT   REPEAT          227..248
FT                   /note="LRR 8"
FT   DOMAIN          260..311
FT                   /note="LRRCT"
FT   LIPID           447
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        82
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   CARBOHYD        372
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   DISULFID        27..33
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   DISULFID        31..43
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   DISULFID        264..287
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   DISULFID        266..335
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   DISULFID        309..336
FT                   /evidence="ECO:0000269|PubMed:29095159,
FT                   ECO:0007744|PDB:5O0K, ECO:0007744|PDB:5O0L,
FT                   ECO:0007744|PDB:5O0M, ECO:0007744|PDB:5O0N,
FT                   ECO:0007744|PDB:5O0O, ECO:0007744|PDB:5O0P,
FT                   ECO:0007744|PDB:5O0Q, ECO:0007744|PDB:5O0R"
FT   STRAND          32..34
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          36..38
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          40..42
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          60..63
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   TURN            74..79
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          85..87
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   TURN            98..103
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          109..111
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   TURN            123..128
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          134..136
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          138..140
FT                   /evidence="ECO:0007744|PDB:5O0K"
FT   TURN            147..152
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          158..160
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   TURN            171..176
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          182..184
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   TURN            195..200
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          206..208
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   TURN            219..224
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          230..232
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           243..246
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          254..256
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           266..268
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           269..277
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          280..282
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   STRAND          286..290
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           291..293
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           298..300
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           303..306
FT                   /evidence="ECO:0007744|PDB:5O0M"
FT   HELIX           321..323
FT                   /evidence="ECO:0007744|PDB:5O0O"
FT   HELIX           326..329
FT                   /evidence="ECO:0007744|PDB:5O0O"
FT   HELIX           334..336
FT                   /evidence="ECO:0007744|PDB:5O0M"
SQ   SEQUENCE   473 AA;  50987 MW;  14C5270EBF557E7C CRC64;
     MKRASSGGSR LLAWVLWLQA WRVATPCPGA CVCYNEPKVT TSCPQQGLQA VPTGIPASSQ
     RIFLHGNRIS HVPAASFQSC RNLTILWLHS NALARIDAAA FTGLTLLEQL DLSDNAQLHV
     VDPTTFHGLG HLHTLHLDRC GLRELGPGLF RGLAALQYLY LQDNNLQALP DNTFRDLGNL
     THLFLHGNRI PSVPEHAFRG LHSLDRLLLH QNHVARVHPH AFRDLGRLMT LYLFANNLSM
     LPAEVLMPLR SLQYLRLNDN PWVCDCRARP LWAWLQKFRG SSSEVPCNLP QRLADRDLKR
     LAASDLEGCA VASGPFRPIQ TSQLTDEELL SLPKCCQPDA ADKASVLEPG RPASAGNALK
     GRVPPGDTPP GNGSGPRHIN DSPFGTLPSS AEPPLTALRP GGSEPPGLPT TGPRRRPGCS
     RKNRTRSHCR LGQAGSGASG TGDAEGSGAL PALACSLAPL GLALVLWTVL GPC
//
